Skip Navigation

Cardiovascular Research 1995 30(2):187-192; doi:10.1016/S0008-6363(95)00025-9
© 1995 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hattori, Y.
Right arrow Articles by Shimoda, S.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, Y.
Right arrow Articles by Shimoda, S.-I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1995, European Society of Cardiology

Vesnarinone inhibits induction of nitric oxide synthase in J774 macrophages and rat cardiac myocytes in culture

Yoshiyuki Hattori*, Shinbu So, Sachiko Hattori, Kikuo Kasai and Shin-Ichi Shimoda

Department of Endocrinology, Internal Medicine, Dokkyo University School of Medicine, Mibu, Tochigi 321-02, Japan

* Corresponding author. Tel. (282)-87-2150; Fax. (282)-86-4632.

Objective: We investigated whether vesnarinone alters the induction of nitric oxide (NO) synthesis by bacterial lipopolysaccharide (LPS) or in combination with interferon-{gamma} in cultured J774 macrophages and rat cardiac myocytes. Methods: The induction of NO synthesis was determined by measuring the stable end-product nitrite. The cytotoxic effect of vesnarinone was assessed by measuring cell respiration. Any change in mRNA levels for NO synthase (NOS) was determined by RT-PCR. Results: Stimulation by LPS or in combination with interferon-{gamma} increased the accumulation of nitrite in the supernatant of J774 macrophages or cardiac myocytes. NOS induction accounted for this accumulation of nitrite, as dexamethasone. NG-methyl-L-arginine, and cycloheximide each reduced the production of nitrite in both types of cells. Vesnarinone produced a significant decline in the cumulative production of nitrite in both types of cells without evidence of cytotoxicity. However, the addition of vesnarinone after induction of NOS did not inhibit nitrite production. Treatment with LPS or in combination with interferon-{gamma} led to a significant expression of NOS mRNA in both types of cells that was significantly reduced by vesnarinone. Conclusions: Vesnarinone inhibited NO synthesis by inhibiting the induction of NOS in J774 macrophages and cardiac myocytes. This drug may exert a beneficial effect in patients with heart failure, in part, by attenuating the production of NO.

KEYWORDS Vesnarinone; Nitric oxide; Macrophages; Rat ventricular myocytes; Cytokines


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Ishiyama, M. Hiroe, T. Nishikawa, T. Shimojo, T. Hosokawa, I. Ikeda, T. Toyozaki, T. Kasajima, and F. Marumo
Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats
Cardiovasc Res, August 1, 1999; 43(2): 389 - 397.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Kurosaki, U. Ikeda, Y. Maeda, M. Shimpo, S. Ueno, and K. Shimada
Effects of vesnarinone on nitric oxide synthesis in rat cardiac myocytes
Cardiovasc Res, April 1, 1998; 38(1): 192 - 197.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.